This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignees: Memorial Sloan Kettering Cancer Center, Tri-Institutional Therapeutics Discovery Institute. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 621 
1 out of 11 Years Active: 2026
Title: Isabell Schulze: Inventor in Cancer Research
Introduction
Isabell Schulze is an inventor associated with New York, NY, and research in therapeutic discovery. Her patent work includes 1 patent concerning CD40-binding molecules and their potential uses.
Latest Patents
Schulze is named on the patent “CD40 Binding Molecules and Uses Thereof.” The invention focuses on molecules that bind CD40, a target studied in cancer immunology, and their possible therapeutic applications.
Career Highlights
Schulze has been associated with the Tri-Institutional Therapeutics Discovery Institute and Memorial Sloan Kettering Cancer Center. These organizations support research and the development of potential therapies.
Collaborations
Her listed collaborators include Taha Merghoub and Jedd David Wolchok, researchers whose work is connected to cancer immunology and treatment.
Conclusion
Isabell Schulze’s patent on CD40-binding molecules reflects her involvement in therapeutic discovery and collaborative cancer research in New York.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile